(Q58023776)

3

0 references

Andreas Hochhaus

object named as

A Hochhaus

8

0 references

author name string

F X Gruber

1

0 references

T Ernst

2

0 references

R A Engh

4

0 references

J Maier

6

0 references

T Lange

https://scigraph.springernature.com/pub.10.1038/leu.2011.187

7

0 references

publication date

5 August 2011

0 references

published in

Leukemia

0 references

volume

26

0 references

issue

1

0 references

page(s)

172-177

0 references

exact match

0 references

cites work

Overriding imatinib resistance with a novel ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Dynamics of chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Resistance to tumor specific therapy with imatinib by clonal selection of mutated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187

inferred from DOI database lookup

7 January 2021

based on heuristic

Detection of drug-resistant clones in chronic myelogenous leukemia patients during dasatinib and nilotinib treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.187